Akamai Technologies

Akamai to buy rival Cotendo for $268 mln


Akamai Technologies (NASDAQ:AKAM) saw its stock jump nearly 20 percent Thursday after the company agreed to acquire its rival Cotendo for $268 million, as it seeks to expand innovations for cloud and mobile optimization.

Under the deal, Akamai said it will buy Cotendo’s outstanding equity for $268 million and will assume unvested stock options. 

Akamai said the combination of its technologies and expertise with Contendo’s integrated suite of Web and mobile acceleration services is expected to increase the pace of innovation in the areas of cloud as well as mobile optimization.

Shares of Akamai surged by 19.54 percent rising to $31.88 apiece today on Nasdaq.

Akamai’s chief executive, Paul Sagan said: "As we look to accelerate growth across the dynamic landscapes of cloud and mobile optimization, we are excited to be joining forces with Cotendo.

"Together, we believe there is tremendous opportunity for our combined technologies as enterprises embrace the move to the cloud and seek solutions for an increasingly mobile world.

Cotendo, founded in 2008 and based in Sunnyvale, California, is a content delivery network and an application delivery network service provider.
It has about 100 workers half of them in Israel where it has a technology centre.

Akamai provides services for accelerating and improving the delivery of content and applications, also called cloud computing, through the Internet.  

The closing of the transaction, which is subject to customary closing conditions, including regulatory approvals, is slated in the first half of 2012.

Akamai had sued Cotendo last year for patent infringement; it had also sued, and afterwards bought, Speedera in 2005.

Quick facts: Akamai Technologies

Price: $86.65

Market: NASDAQ
Market Cap: $14.3 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 12 hours ago

2 min read